How malaria affects the immune response to the Ebola vaccine
Evaluating the impact of malaria on immunogenicity of the Ebola virus vaccine
This study looks at how malaria might affect how well the Ebola vaccine works, especially in places where both diseases are common, to help improve vaccination strategies and protect people better during outbreaks.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10996333 on NIH RePORTER |
What this research studies
This research investigates how malaria infections impact the effectiveness of the Ebola virus vaccine, particularly in regions where both diseases are prevalent. By studying the immune responses in a controlled mouse model, the research aims to understand the mechanisms by which malaria may hinder the body's ability to respond to the Ebola vaccine. The findings could provide insights into improving vaccination strategies in areas heavily affected by both malaria and Ebola, ultimately enhancing public health responses during outbreaks.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in Central and West Africa who are at risk of both malaria and Ebola virus infection.
Not a fit: Patients who do not reside in malaria-endemic regions or who have already been vaccinated against Ebola may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccination strategies against Ebola in malaria-endemic regions, potentially saving lives during outbreaks.
How similar studies have performed: Previous research has indicated that malaria can interfere with vaccine efficacy, suggesting that this approach may yield valuable insights into vaccine responses.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Elliff, Jonah — University of Iowa
- Study coordinator: Elliff, Jonah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.